DK0588903T3 - Bestemmelse af opløselig HLA kompatibilitet - Google Patents

Bestemmelse af opløselig HLA kompatibilitet

Info

Publication number
DK0588903T3
DK0588903T3 DK92912658T DK92912658T DK0588903T3 DK 0588903 T3 DK0588903 T3 DK 0588903T3 DK 92912658 T DK92912658 T DK 92912658T DK 92912658 T DK92912658 T DK 92912658T DK 0588903 T3 DK0588903 T3 DK 0588903T3
Authority
DK
Denmark
Prior art keywords
hla
antibodies
human
determination
recipient
Prior art date
Application number
DK92912658T
Other languages
Danish (da)
English (en)
Inventor
Philippe Pouletty
Original Assignee
Sangstat Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangstat Medical Corp filed Critical Sangstat Medical Corp
Application granted granted Critical
Publication of DK0588903T3 publication Critical patent/DK0588903T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
DK92912658T 1991-06-05 1992-05-28 Bestemmelse af opløselig HLA kompatibilitet DK0588903T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/710,710 US5223397A (en) 1991-06-05 1991-06-05 Soluble hla cross-match
PCT/US1992/004486 WO1992021978A1 (fr) 1991-06-05 1992-05-28 Determination de la compatibilite de hla soluble

Publications (1)

Publication Number Publication Date
DK0588903T3 true DK0588903T3 (da) 2000-01-24

Family

ID=24855193

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912658T DK0588903T3 (da) 1991-06-05 1992-05-28 Bestemmelse af opløselig HLA kompatibilitet

Country Status (9)

Country Link
US (1) US5223397A (fr)
EP (1) EP0588903B1 (fr)
JP (1) JPH06508687A (fr)
AT (1) ATE182007T1 (fr)
CA (1) CA2103151A1 (fr)
DE (1) DE69229553T2 (fr)
DK (1) DK0588903T3 (fr)
ES (1) ES2136089T3 (fr)
WO (1) WO1992021978A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482841A (en) * 1994-05-24 1996-01-09 Sangstat Medical Corporation Evaluation of transplant acceptance
US5785966A (en) * 1994-06-15 1998-07-28 Coles; John G. Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
US5948627A (en) * 1997-05-30 1999-09-07 One Lambda Immunobead flow cytometric detection of anti-HLA panel-reactive antibody
US6046013A (en) * 1997-08-01 2000-04-04 Gti Process for identifying specific antibodies associated with HLA
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6921751B1 (en) * 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US8609436B2 (en) * 2000-03-17 2013-12-17 Guy's & St Thomas' Hospital NHS Trust (“GST”) Method
US8088586B2 (en) * 2000-03-17 2012-01-03 Oxford Radcliffe Hospital Nhs Trust Method of producing a body fluid sample depleted of anti-MHC antibodies
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (fr) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Régulation génétique par des oligopeptides
US20030224995A1 (en) * 2001-12-21 2003-12-04 Khan Nisar Ahmed Treatment of burns
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20030220260A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Peptide compositions
US7501391B2 (en) * 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20040013661A1 (en) * 2001-12-21 2004-01-22 Gert Wensvoort Stratification
US20030220261A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Treatment of iatrogenic disease
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20040241764A1 (en) * 2003-06-02 2004-12-02 Uri Galili Early detection of recipient's immune response against heart transplant
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
SG163567A1 (en) * 2005-07-05 2010-08-30 Biotempt Bv Treatment of tumors
EP1864692A1 (fr) * 2006-06-07 2007-12-12 Biotempt B.V. Utilisation de peptides pour la protection contre les radiolésions
PL2120991T3 (pl) * 2007-02-12 2014-07-31 Biotempt Bv Leczenie urazów krwotocznych krótkimi oligopeptydami
EP2353005B1 (fr) 2008-12-01 2018-10-03 The Board of Trustees of The Leland Stanford Junior University Procédés et compositions pour la détection d'anticorps fixant le complément
AU2014236882B2 (en) 2013-03-14 2019-01-31 The Board Of Trustees Of The Leland Stanford Junior University Methods of detecting donor-specific antibodies and systems for practicing the same
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same
CN109283037A (zh) * 2018-09-03 2019-01-29 万峰春 一种交叉配型检验装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891319A (en) * 1985-07-09 1990-01-02 Quadrant Bioresources Limited Protection of proteins and the like
US4895706A (en) * 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US4959308A (en) * 1987-08-27 1990-09-25 Board Of Regents, The University Of Texas System Immunoassay for antibodies binding platelets

Also Published As

Publication number Publication date
US5223397A (en) 1993-06-29
DE69229553T2 (de) 1999-11-25
WO1992021978A1 (fr) 1992-12-10
EP0588903A4 (en) 1994-06-29
ES2136089T3 (es) 1999-11-16
CA2103151A1 (fr) 1992-12-06
JPH06508687A (ja) 1994-09-29
DE69229553D1 (de) 1999-08-12
EP0588903B1 (fr) 1999-07-07
ATE182007T1 (de) 1999-07-15
EP0588903A1 (fr) 1994-03-30

Similar Documents

Publication Publication Date Title
DK0588903T3 (da) Bestemmelse af opløselig HLA kompatibilitet
NO980030L (no) Monoklonale antistoffer som binder CD40-L
EP0375422A3 (fr) Composé et procédés pour la détermination de la présence des amphétamines dans un échantillon suspect de contenir de l'amphétamine et/ou de la méthamphétamine
MY104946A (en) Antigen antibody conjugate.
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
AU619183B2 (en) A one-step immunoassay for the determination of antigen-specific antibodies of one of the immunoglobulin classes a,m,d or e, and an agent suitable for this purpose
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
GB2255637B (en) Separation method
TW222686B (fr)
DE69231495T2 (de) Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen
DK0638175T3 (da) In vitro-test for Helicobacter pylori
EP0366092A3 (fr) Procédé pour déterminer des anticorps antigène- et classes-spécifiques et réactif pour ce procédé
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
ES2084581T3 (es) Inmunoensayos que utilizan antigenos producidos en organismos hetereologicos.
AU5456186A (en) Detection of human T-cell leukemia virus type III
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin
DK0558361T3 (da) Sensibiliserede erythrocytter, fremgangsmåde til fremstilling heraf og anvendelse heraf
EP0339633A3 (fr) Anticorps monoclonal contre le cancer gastrique humain
KR860008779A (ko) 항체 형성 화합물의 제조방법
IT1254955B (it) Anticorpi monoclonali murini diretti contro il polisaccaride capsulare di streptococchi di gruppo b di tipo iii
NO903788D0 (no) Monoklonalt antistoff mot protein c.